title: Improved immunohistochemical staining of angiotensin II in rat brain using affinity purified antibodies.
abstract: Recent immunohistochemical studies that have sought to detect angiotensin II/III (AII/AIII) immunoreactive material in the brain have been forced to rely on a small number of antisera because most AII/AIII antibodies have unexplainably proved unsuitable for immunohistochemistry. Although extremely useful tools, these antisera have suffered from high background staining. The purpose of this study was to re-examine and characterize the staining using the most popular AII/AIII antiserum (Denise) before and after purification on an AII CH-sepharose affinity column. The use of crude AII/AIII antiserum resulted in the staining of large varicosities and cell bodies. Fibres were all but invisible owing to extensive background staining. In contrast, the purified antibodies yielded little background staining and produced a discrete staining of AII/AIII fibres with small varicosities in the paraventricular-hypophysial pathway and of cell bodies of large hypothalamic neurones. In addition punctate staining demarcated the perikarya of some neurones and resembled boutons containing immunoreactive AII/AIII. Biochemical and histochemical analysis of the crude antiserum, the affinity purified antibodies and other fractions off the sepharose column demonstrated that a large portion of the total staining (various types of background) seen with crude antiserum and column fractions was not to AII/AIII or several angiotensin-derived fragments. Furthermore, successful preabsorption blanks for the purified antibodies could only be achieved with AII coupled through its N-terminal, suggesting that these purified antibodies reacted best with conjugated angiotensin in the fixed tissue. In total the results of this study indicate that the background staining seen with crude antiserum is not to AII/AIII. The use of affinity purified antibodies greatly enhances resolution, enabling one to visualise even small fibres in rats not treated with colchicine, and should improve our ability to develop accurate maps of central angiotensinergic pathways.
authors.affiliation: Division of Animal Physiology, University of Berne, Switzerland.
authors.forename: H
authors.initials: H
authors.lastname: Imboden
authors.forename: J W
authors.initials: JW
authors.lastname: Harding
authors.forename: R H
authors.initials: RH
authors.lastname: Abhold
authors.forename: D
authors.initials: D
authors.lastname: Ganten
authors.forename: D
authors.initials: D
authors.lastname: Felix
mesh_terms: D000804:Angiotensin II / Q000032:analysis* / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000302:isolation & purification; D001921:Brain / Q000166:cytology*; D002846:Chromatography, Affinity; D007124:Immunoenzyme Techniques; D008297:Male; D051381:Rats; D011921:Rats, Inbred WKY
chemical_list: D000906:Antibodies; D000804:Angiotensin II